DnB Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $452K | Sell |
9,585
-726
| -7% | -$34.3K | ﹤0.01% | 657 |
|
|
2025
Q1 | $403K | Buy |
10,311
+1,955
| +23% | +$76.4K | ﹤0.01% | 671 |
|
|
2024
Q4 | $452K | Buy |
8,356
+847
| +11% | +$45.9K | ﹤0.01% | 668 |
|
|
2024
Q3 | $379K | Buy |
7,509
+137
| +2% | +$6.91K | ﹤0.01% | 670 |
|
|
2024
Q2 | $324K | Buy |
7,372
+1,694
| +30% | +$74.5K | ﹤0.01% | 671 |
|
|
2024
Q1 | $285K | Buy |
+5,678
| New | +$285K | ﹤0.01% | 679 |
|